Milacron Milacron's Q3 overview reflects a solid quarter

Editor: Briggette Jaya

Global industrial technology company Milacron has just announced its financial results for the third quarter, which ended 30 September 2018.

Related Vendors

Milacron celebrates a landmark milestone this fall with its 50th Anniversary in Plastics.
Milacron celebrates a landmark milestone this fall with its 50th Anniversary in Plastics.
(Source: Milacron)

In Q3 of 2018, U.S.-based Milacron's sales noted at $308.3 million marked a dip of 2.0% from $314.7 million in the same period a year ago. Excluding the unfavorable effects of currency movements, organic sales decreased 0.3% versus the prior year period, while operating earnings was up 11.4% at $33.2 million compared to the same period last year. Net earnings totaled $14.9 million, equivalent to $0.21 per basic and diluted share in Q3 2018. Adjusted Net Income totaled $30.7 million, equivalent to $0.43 per diluted share in Q3.

“Milacron continued to execute on its long-term growth initiatives and delivered another solid quarter including solid sales," said Milacron Chief Executive Officer, Tom Goeke. "These results are in spite of the continued geopolitical uncertainty the U.S. tariff initiatives have introduced to our global end markets."

The global company's Chief Financial Officer, Bruce Chalmers, added: "We continue to strengthen our balance sheet by making voluntary debt payments on our term loan. Through the third quarter, we have paid down $75 million of debt. "

In line with current market conditions, Milacron forecasts 2% sales growth in 2018, which is inclusive of an anticipated 1% foreign currency tailwind.

The full report is available at here.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent